Clover Health Investments Corp. Hits New 52-Week High at $4.43

Clover Health Investments Corp. has reached a significant milestone by hitting a new 52-week high of USD 4.43 on June 9, 2026. This achievement marks a notable increase from its 52-week low of USD 1.58, reflecting a substantial upward trend in the stock's performance over the past year. In the context of the broader market, Clover Health's performance has outpaced the S&P 500, with a year-over-year increase of 22.99%. The company operates within the insurance industry and holds a market capitalization of approximately USD 971 million, categorizing it as a small-cap stock. Despite its recent price surge, Clover Health remains in a loss-making position, as indicated by its negative price-to-earnings ratio and a return on equity of -27.71%. The company's price-to-book ratio stands at 3.15, and it currently does not offer a dividend yield. As Clover Health continues to navigate the competitive landscape of the insurance sector, its recent price movement highlights the evolving dynamics within the market.